Gene expression ratios of all IL1B, CASP1 and IRAK1, to IL1RN were higher in AML patients (Fig. 1e; Supplementary Fig. S1D), suggesting that reduced IL-1RN associates with activation of IL-1β pathway. The gene discussed is IRAK1; the disease is acute myeloid leukemia.